Update shared on 07 Dec 2025
Fair value Increased 1.71%Analysts have raised their price target on Cencosud modestly, from CLP 3,139.09 to CLP 3,192.73, citing a slightly richer profit margin outlook and lower expected future valuation multiples. These factors more than offset tempered revenue growth assumptions and a marginally higher discount rate.
Valuation Changes
- Fair Value has risen slightly to CLP 3,192.73 from CLP 3,139.09, reflecting a modestly more constructive intrinsic valuation.
- Discount Rate has increased marginally to 11.04 percent from 10.85 percent, indicating a slightly higher required return on equity.
- Revenue Growth expectations have eased moderately to 3.73 percent from 4.08 percent, pointing to a somewhat softer top line outlook.
- Net Profit Margin is expected to improve modestly to 4.88 percent from 4.49 percent, supporting a more favorable earnings profile.
- Future P/E has declined slightly to 12.31 times from 13.09 times, suggesting a lower valuation multiple applied to forward earnings.
Have other thoughts on Cencosud?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.